Literature DB >> 19011494

Explaining "unexplained" perinatal loss: experiences of women with antiphospholipid syndrome.

Susan Mathew1, Sandra Cesario, Lene Symes.   

Abstract

OBJECTIVE: To explore women's experiences of 1 or more perinatal losses associated with antiphospholipid syndrome (APS) and describe their perceptions about losses related to this disorder and its effects on both their outlook and subsequent childbearing.
SUBJECTS: The participants included thirty-eight 18- to 50-year-old women from 5 countries, who were members of general and APS online perinatal support groups and had 1 or more perinatal losses associated with APS.
METHODS: The respondents were recruited from various online perinatal loss support groups, using convenience and snowball sampling. Semistructured e-mail interviews were conducted, using the qualitative technique of phenomenology.
RESULTS: Two major themes that emerged from the data are existence in bewilderment and persistence in the quest for knowledge and information. The first theme has 2 subthemes: delayed diagnosis and living in uncertainty.
CONCLUSION: Women with APS and related perinatal losses perceive the need to persist in seeking scientific knowledge because the information they receive from healthcare providers is limited and unclear. Evidence-based medical and nursing education about antiphospholipid antibody syndrome is necessary to improve clinical practice and thereby the perinatal outcome and the ill effects of this condition for women during and after the childbearing period.

Entities:  

Mesh:

Year:  2008        PMID: 19011494     DOI: 10.1097/01.JPN.0000341360.37822.7d

Source DB:  PubMed          Journal:  J Perinat Neonatal Nurs        ISSN: 0893-2190            Impact factor:   1.638


  2 in total

1.  Diagnosis and treatment of patients with antiphospholipid syndrome: a mixed-method evaluation of care in The Netherlands.

Authors:  Mirthe J Klein Haneveld; Caro H C Lemmen; Tammo E Brunekreef; Marc Bijl; A J Gerard Jansen; Karina de Leeuw; Julia Spierings; Maarten Limper
Journal:  Rheumatol Adv Pract       Date:  2020-06-12

Review 2.  Organ Damage and Quality of Life in Antiphospholipid Syndrome.

Authors:  P Alba; J A Gómez-Puerta; M V Goycochea-Robles; M C Amigo
Journal:  Curr Rheumatol Rep       Date:  2016-02       Impact factor: 4.592

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.